| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | china |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
L-Polaprezinc
zinc 2-[(3-azanidyl-1-oxido-propylidene)amino]-3-(3H-imidazol-4-yl)propanoate; histidine, β-alanyl-, zinc salt (1:1)
CAS:107667-60-7
C9H12N4O3Zn
289.63
Specific rotation: +8 degrees to +9 degrees
Loss on drying:≤2.5%
Assay: the assay is 98.0%-102.0% if calculated based on carnosine, it is 97.0%-102.0% if calculated based on zinc. Art No. AIE0009A
Related substance:single impurit≤0.1%,total impurity≤1.0%.
Property: white powder, insoluble in water, difficultly soluble in organic solvent.
Packing: 5kg, 25kg /cardboard drum, it is lined with polyethylene bag and kraft paper bag inside.
Storage: It should be stored in a dry and well ventilated place.
Application:
It is anti ulcer new drug, it can also be used for the prevention and treatment of alcoholic liver disease, viral hepatitis or other liver disease induced by drugs, poisons and radiation
沪公网安备31010402001403号
